Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2021, 3(4); doi: 10.25236/FMSR.2021.030408.

Research Progress of Oral Chinese Medicine in Treating Ulcerative Colitis and Its Pathogenesis

Author(s)

Dai Rui1, Du Xiaoquan2

Corresponding Author:
Du Xiaoquan
Affiliation(s)

1Shaanxi University of Traditional Chinese Medicine, Shaanxi, 712000, China

2Department of Gastroenterology II,the First Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Shannxi,712046,China

Abstract

Ulcerative colitis is a common and difficult disease of the digestive system, which has the characteristics of long course of disease and easy to repeat the condition. Studies have shown that with the extension of the course of the disease, patients with ulcerative colitis also have an increased chance of colon cancer. Western medicine still lacks specific and effective treatments for this disease, but traditional Chinese medicine in the treatment of ulcerative colitis in continuous in-depth research and testing, has made a series of progress, and traditional Chinese medicine in the treatment of this disease has the characteristics of high cost performance, fewer adverse reactions, so it is gradually accepted by patients in the clinical treatment. This article intends to summarize the research on oral treatment of ulcerative colitis with traditional Chinese medicine in recent years, and systematically elaborate its related mechanism of action, in order to provide new ideas for the clinical research and diagnosis and treatment of ulcerative colitis in the future.

Keywords

Ulcerative colitis, Chinese medicine, Pathogenesis, Research progress, Review

Cite This Paper

Dai Rui, Du Xiaoquan. Research Progress of Oral Chinese Medicine in Treating Ulcerative Colitis and Its Pathogenesis. Frontiers in Medical Science Research (2021) Vol. 3 Issue 4: 43-50. https://doi.org/10.25236/FMSR.2021.030408.

References

[1] Ungaro R,Mehandru S,Allen PB, et al. Ulcerative Colitis[J]. The Lancet, 2017, 389 (10080) :1756-1770.

[2] Yamamoto-Furusho J K,Gutierrez-Grobe Y,Lopez-Gomez J G, et al. The Mexican Consensus on the Diagnosis and Treatment of Ulcerative Colitis.[J]. Revista De Gastroenterologia De Mexico, 2018, 83(2):144-167.

[3] Xinyu X,Zhe C,Fan W, et al. Berberine in the Treatment of Ulcerative Colitis: a Possible Pathway Through Tuft Cells[J]. Biomedicine & Pharmacotherapy, 2020, 134:111129-111129.

[4] Youn-hwan H,Yeul MJ. Preventive Effects of an Uplc-dad-ms/ms Fingerprinted Hydroalcoholic Extract of Citrus Aurantium in a Mouse Model of Ulcerative Colitis.[J]. Planta Medica, 2018,84(15):1101-1109.

[5] Mingxing P. Study on the Regulation Mechanism of Sanbai Tang on TLR4/NF-κB Signaling Pathway in Ulcerative Colitis Rats [D]. Hubei University for Nationalities, 2020.

[6] Weiwei Z, Lianren M, Ling Z. The Effect of Gegenqinlian Decoction combined with Guchang Zhixie Pill on ulcerative colitis and its effect on serum IL-1, IL-6, TNF-α levels.[J]. Chinese Archives of Traditional Chinese Medicine: 1-10.

[7] Ping L. To explore the mechanism of Qingchang Huashi Decoction in treating mucosal injury of ulcerative colitis from intestinal microecology [D]. Beijing University of Chinese Medicine, 2018.

[8] Yalan L, Jiajing L, Peiguang M, et al. Gegen Qinliantang regulates MMP-9/p38MARK pathway to repair intestinal mucosal barrier function in mice with ulcerative colitis [J]. Chinese Journal of Experimental Traditional Medical Formulae,2021,27(04):8-15.

[9] Yi L, Yan L, Yongpan X, et al. Efficacy of Kangfuxin Solution Combined with Mesalazine in the Treatment of Ulcerative Colitis and its Effect on Serum Inflammatory Factors and T Lymphocyte Levels [J]. West China Journal of Pharmaceutical Sciences, 2017, 32(1): 111-112.

[10] Huiying X,Mingjun D. Clinical Research Progress of Traditional Chinese Medicine in Ulcerative Colitis[J]. Popular Science & Technology, 2020, 22(9): 84-87.

[11] Yule R, Xianhong J. Clinical Thinking of Ulcerative Colitis in TCM [J]. Zhejiang Journal of Traditional Chinese Medicine,2020, 55(12): 918-919.

[12] Ya L, Yan L, Yanhong Q, et al. Effect of Jianpi Yiqi, Qingre Huafu Shengji Recipe combined with Mesalazine on the intestinal mucosal barrier function of Patients with Ulcerative Colitis [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2021, 29(7): 455-459, 463.

[13] Kai C, Min Z, Jingtao S. Professor Sha Jingtao's Experience in Treating Ulcerative Colitis by Using the Theory of Invigorating the Spleen and Removing Dampness [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2021, 30(20): 2228-2231.

[14] Jonathan L,Emma R,Nick E, et al. Tight Junctions in Inflammatory Bowel Diseases and Inflammatory Bowel Disease Associated Colorectal Cancer.[J]. World Journal of Gastroenterology, 2016, 22(11):3117-3126.

[15] Riddell Robert H. IBD: Mucosal Healing in Ulcerative Colitis: What Constitutes Remission?[J]. Nature Reviews. Gastroenterology & Hepatology, 2017, 14(1):5-6.

[16] Jin Z, Ying Z, Yubo C, et al. Effect of Kuijiening Ointment Acupoint Application on Colonic Mucosal Barrier in rats with Ulcerative Colitis [J]. Journal of Emergency in Traditional Chinese Medicine, 2019, 28(11): 1934-1937.

[17] Deborah F,Véronique A,Laurence V, et al. Hematopoietic Protease Nexin-1 Protects Against Lung Injury By Preventing Thrombin Signaling in Mice.[J]. Blood Advances, 2018, 2(18):2389-2399.

[18] Yuan Y, Qiuhua W, Yuanjie C, etc. Regulatory effect of Tongxie Yaofang on immune function and intestinal mucosal barrier in patients with Ulcerative Colitis [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2020, 28(11): 858-862.

[19] Wenjuan Z, Xin H. Clinical observation on treating Ulcerative Colitis of the Pixu Shizu type with Shenling Baizhu San plus mesalazine tablets[J]. Clinical Journal of Chinese Medicine, 2020, 12(19): 78-80.

[20] Honghui D. Efficacy Analysis of Shaoyao Decoction Combined with Mesalazine in Treating Ulcerative Colitis of Dampness-heat Intrinsic Type [J]. Chinese Journal of Traditional Medical Science and Technology, 2019, 26(5): 744-745.

[21] Jinzhong Z. Efficacy Analysis of Modified Fuzi Lizhong Decoction in the Treatment of Ulcerative Colitis of Spleen and Kidney Yang Deficiency Type [J]. China Practical Medicine 2019, 14(3): 124-125.

[22] Mengni S, Qianhui F, Yu L, et al. Effects of Poteneilla Discolor Bunge on proinflammatory and chemokines in TNBS induced acute ulcerative colitis rats[J]. Journal of Basic Chinese Medicine, 2020, 26(10): 1475-1478, 1534.

[23] Jiamin Q, Xiaolong C, Zhaoqiang J.Difference of Numb, NLRP3 and IL-1 β expression in resting and onset stages of Ulcerative Colitis and its Clinical Significance [J]. International Journal of Digestive Diseases, 2020, 40(4): 256-259.

[24] Bolin L, Danyang Z, Pengli D, et al. Effect of Turbidity-Resolving and Toxin-Removing Recipe on Serum Levels of IL-1 β and IL-8 and Colonic Mucosal NF-κB mRNA Expression in Rats with Ulcerative Colitis [J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2019, 36(7): 1045-1049.

[25] Xi C, Yupeng H, Gang C, et al. Effect of bone marrow mononuclear cell transplantation on the expression of miR-21 and inflammatory factor TNF-α in mice with ulcerative colitis [J]. Chinese Journal of Gerontology, 2020, 40(10): 2190-2192.

[26] Hua Z, Lu Z, Xiaolin W, et al. Effect of Ligustrazine on Serum IL-10 and NF-κ B in Patients with Ulcerative Colitis [J]. Chinese Journal of Health Care and Medicine, 2018, 20(3): 255-256.

[27] Yanqi S,Guiye A, Zilei H, et al. Effect of Huazhuo Qingjie Yukui Decoction on p38MAPK, TNF-α,IL-4 in Ulcerative Colitis Rats [J]. Journal of Emergency in Traditional Chinese Medicine, 2020, 29(2): 206-209, 252.

[28] Guangru Z. Effect and Mechanism of Shaoyao Decoction in the Treatment of Patients with Ulcerative Colitis [J]. China Journal of Pharmaceutical Economics, 2020, 15(11): 100-103.

[29] Jiulin Y, Cansheng L, Jian S.Clinical study of Baitouweng Decoction on Hemorheology in patients with Ulcerative Colitis [J]. Clinical Journal of Traditional Chinese Medicine, 2020, 32(12): 2343-2346.

[30] Guanggang Z. Clinical effect and safety of Fuzi Lizhong decoction for Ulcerative Colitis [J]. Chinese Journal of Clinical Rational Drug Use, 2019, 12(24): 28-29.

[31] Hua W. Clinical Study on Wumei Pills combined with 5-aminosalicylic acid in treatment of Ulcerative Colitis [J]. Drugs & Clinic, 2016, 31(5): 650-653.

[32] Goudarzi R,Partoazar A,Mumtaz F, et al. Arthrocen, an Avocado‐soy Unsaponifiable Agent, Improves Acetic Acid‐induced Colitis in Rat By Inhibition of Nf‐kb Signaling Pathway[J]. Journal of Food Biochemistry, 2020, 44(7).

[33] Cummins Eoin P,Daniel C. Hypoxia and Inflammatory Bowel Disease.[J]. Microbes and Infection, 2017, 19(3):210-221.

[34] Jiang W,Han Y-P,Hu M, et al. A Study on Regulatory Mechanism of Mir-223 in Ulcerative Colitis Through Pi3k/akt-mtor Signaling Pathway.[J]. European Review for Medical and Pharmacological Sciences, 2019, 23(11):4865-4872.

[35] Yue H. Evaluation of Therapeutic effect of modified and Tongxie Yaofang in the treatment of Ulcerative Colitis and network pharmacology research [D]. Nanjing University of traditional Chinese medicine, 2020.

[36] Houpan S, Xiaojuan C, Meiyan Z, et al. Molecular network regulation mechanism of Bai-Tou-Weng-Tang in the treatment of ulcerative colitis [J].Chinese Journal of Hospital Pharmacy, 2020, 40(10): 1098-1105.

[37] Sartor RB,Wu GD. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches[J]. Gastroenterology, 2017, 152(2):327-339.

[38] Yuan Z,Yang L,Zhang X, et al. Therapeutic Effect of N-butanol Fraction of Huang-lian-jie-du Decoction on Ulcerative Colitis and Its Regulation on Intestinal Flora in Colitis Mice[J]. Biomedicine & Pharmacotherapy, 2020, 121(C):109638.

[39] Shen Z,Zhu C,Quan Y, et al. Relationship Between Intestinal Microbiota and Ulcerative Colitis: Mechanisms and Clinical Application of Probiotics and Fecal Microbiota Transplantation[J]. World Journal of Gastroenterology, 2018, 24(1): 5-14.

[40] Palm NW,Zoete MRD,Cullen TW, et al. Immunoglobulin a Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease[J]. Cell, 2014, 158(5):1000-1010.

[41] Keya L, Zhenquan W, Meiyao P. Efficacy of Wumei Pill on Ulcerative Colitis(Spleen and Kidney Deficiency Cold and Heat Accumulation in Cold Syndrome) and its influence on Intestinal Microecology [J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2020, 26(16): 85-89.

[42] Yuan Y, Qinghua W, Yuanjie C, et al. Effect of Tongxieyaofang on traditional Chinese medicine and intestinal flora in patients with ulcerative colitis [J]. Hunan Journal of Traditional Chinese Medicine, 2020, 36(12): 12-14.

[43] Benyin L. Clinical observation on treatment of ulcerative colitis of Yang-deficiency of spleen and kidney with Mesalazine Combined with Euzilizhong Pill[D]. Nanjing University of traditional Chinese medicine, 2020.

[44] Laurence P,A JJ,Philippe B, et al. Regulatory T Cells and Their Roles in Immune Dysregulation and Allergy.[J]. Immunologic Research, 2014, 58(2-3):358-368.

[45] Hailei H, Qin G. Study on the effect of clearing heat and removing dampness on immune function of ulcerative colitis [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2016, 25(6): 682-684.

[46] Ranson N,Veldhuis M,Mitchell B, et al. Nlrp3-dependent and -independent Processing of Interleukin (il)-1β in Active Ulcerative Colitis[J]. International Journal of Molecular Sciences, 2018, 20(1):57-57.

[47] Zhenbin Y, Xiaohua F, Qingna W, et al. Therapeutic Effects of Yuxian Decoction in the Treatment of Ulcerative Colitis of Large Intestine Damp Heat Type and Its Effects on Th1 / Th2 Cytokines and TGF-β Level[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(12): 18-22.

[48] Min Y,Zhe S,Hui YC, et al. The Therapeutic Role of Oral Tolerance in Dextran Sulfate Sodium-induced Colitis Via Th1-th2 Balance and γδ T Cells.[J]. Journal of Digestive Diseases, 2013, 14(10):543-551.

[49] Leichang Z,Lixia H, Aijiao X, et al. Effect of medicated thread moxibustion of Chinese Zhuang Minority medicine on colonic inflammatory impairment and Th17/IL-17F signaling in rats with ulcerative colitis [J]. Acupuncture Research, 2020, 45(3): 188-193.

[50] Bolin L, Xuemei J, Yanru C, et al. Effects of Huazhuo Jiedu Fang on the levels of serum IL-6,IL-10 and the expression of CD4+,CD8+ T lymphocytes of colonic Mucosa in rats model with ulcerative colitis[J]. Journal of Gansu University of Chinese Medicine, 2019, 36(3): 7-11.

[51] Yanyan S, Jianbo Z. Changes of inflammatory cytokines, T lymphocytes and coagulation function in elderly patients with ulcerative colitis [J].Chinese Journal of Gerontology, 2018, 38(2): 382-384.

[52] Xiang L, Meiqing W. Efficacy of Shenlingbaizhu Powder combined with Mesalazine in the Treatment of Ulcerative Colitis [J].Shaanxi Journal of Traditional Chinese Medicine, 2020, 41(9): 1251-1253.

[53] Qianzhang M, Yun L, Yuanquan D. Clinical Observation of Baitouweng decoction modified combined with Mesalazine sustained release tablets in the treatment of ulcerative colitis with hot toxicity and its effect on immune function and serum inflammatory factor in patients with ulcerative colitis [J]. Journal of Hainan Medical University, 2019, 25(12): 918-922.

[54] Mengzhao S, Jingjing T, Lihong C. Clinical Efficacy and Effect on T-lymphocyte Subgroup of Wumei Pills in Treating Active Ulcerative Colitis[J].Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 2018, 24(5): 545-549.

[55] Weizhen Q, Weifeng Z. Effect of Shenlingbaizhu Powder Combined with Mesalazine on Inflammatory Factors and Immune Function in Children and Adolescents with Ulcerative Colitis[J].Herald of Medicine, 2019, 38(5): 584-588.